In the U.S., Hispanic women have been disproportionately affected^[1] by the HIV epidemic in recent years. Yet they’ve been less likely to take advantage of PrEP, a medication that significantly reduces the risk of getting HIV^[2].

So we created a pilot intervention^[3] to inform more people about the medication by adding it to an existing and proven HIV-prevention program aimed at heterosexual Hispanic women. All of the...